University of Michigan Kellogg Eye Center
University of Michigan Kellogg Eye Center
Ann Arbor, Michigan, United States9 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Juvenile Macular Degeneration, Stargardt Disease 1, Stargardt disease, cone-rod dystrophy, eye disorder, hereditary disease, inherited retinal dystrophy, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Not stated | 2026-10-09 | NCT06445322 | |
| Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Juvenile Macular Degeneration, Stargardt Disease 1, Stargardt disease, cone-rod dystrophy, eye disorder, hereditary disease, inherited retinal dystrophy, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-07 | NCT06467344 | |
| A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP) | X-Linked Retinitis Pigmentosa | Active, not recruiting | Phase 2 | 2026-09-25 | NCT06646289 | |
| Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD | Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 2 | 2026-09-10 | NCT06659445 | |
| Clarifying the Optimal Application of SLT Therapy Trial | eye disorder, glaucoma, ocular hypertension | Recruiting | Phase 3 | 2026-08-14 | NCT04967989 | |
| Natural History of PRPF31 Mutation-Associated Retinal Dystrophy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa | Active, not recruiting | Not stated | 2026-04-13 | NCT05573984 | |
| Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium | Diabetes Complications, Embolism and Thrombosis, Venous Thrombosis, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, macular degeneration, retinal degeneration, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorder | Recruiting | Early phase 1 | 2026-02-04 | NCT04008121 | |
| Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD) | Dry Age-related Macular Degeneration | Recruiting | Phase 1 / Phase 2 | 2025-10-15 | NCT04627428 | |
| 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP) | X-Linked Retinitis Pigmentosa | Active, not recruiting | Phase 1 / Phase 2 | 2025-03-21 | NCT04517149 |